Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Project Beacon operated as a social-benefit, nonprofit/low-profit COVID-19 testing provider focused on high-throughput RT‑PCR testing (processed primarily at the Broad Institute) and rapid antigen testing (e.g., BinaxNOW) for communities, workplaces, and K‑12 schools in Massachusetts, including operating multiple state-sponsored regional express testing sites and providing software to manage pooled and individual testing; it was acquired by Ginkgo Bioworks in January 2022 and folded into Ginkgo’s biosecurity and testing offerings.[1][2][3][6][7]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Project Beacon COVID-19 LLC.